Mankind Pharma Limited has pledged 39.68 per cent of its equity stake in its fully-owned subsidiary Bharat Serums and Vaccines Limited (BSV) to secure non-convertible debentures (NCDs) totalling ₹5,000 crores. This decision comes under SEBI’s Listing Obligations and Disclosure Requirements Regulations, 2015, with Catalyst Trusteeship Limited assigned as the common security trust.
Open FlipDCX Systems' Q2FY25 results were muted due to higher material costs, but order wins of INR 30,000 Mn bring revenue visibility, driving confidence in its EMS prospects in railway and defence spaces, though margins remain under pressure. KR Choksey maintains a BUY rating with a target price of INR 466.
Open Flip📌Indexes slipped Thursday as traders focused on remarks from Fed Chair Jerome Powell. 📌Powell said the Fed is in no hurry to cut rates, and reiterated the strength of the US economy. 📌Traders also digested wholesale inflation data, which was in line with expectations. 📌Powell added the US has had the best domestic growth of any major economy, and emphasized the strength of the labor market.
Open Flip